3-methoxytyramine has been researched along with Sensitivity and Specificity in 8 studies
3-methoxytyramine: RN given refers to parent cpd
3-methoxytyramine : A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas.
Sensitivity and Specificity: Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Measurements of plasma free metanephrines (MNs), including MN and normetanephrine, provide high sensitivity and specificity for the diagnosis of pheochromocytoma and paraganglioma (PPGL)." | 8.12 | Addition of 3-methoxytyramine or chromogranin A to plasma free metanephrines as the initial test for pheochromocytoma and paraganglioma: Which is the best diagnostic strategy. ( Gao, Y; Guo, X; Li, X; Li, Y; Liu, L; Song, Z; Wang, T; Xie, W; Zhang, J, 2022) |
| "Measurements of plasma free metanephrines (MNs), including MN and normetanephrine, provide high sensitivity and specificity for the diagnosis of pheochromocytoma and paraganglioma (PPGL)." | 4.12 | Addition of 3-methoxytyramine or chromogranin A to plasma free metanephrines as the initial test for pheochromocytoma and paraganglioma: Which is the best diagnostic strategy. ( Gao, Y; Guo, X; Li, X; Li, Y; Liu, L; Song, Z; Wang, T; Xie, W; Zhang, J, 2022) |
| "Measurements of plasma or urinary metanephrines are recommended for diagnosis of pheochromocytoma and paraganglioma (PPGL)." | 3.88 | Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated ( Beuschlein, F; Deutschbein, T; Eisenhofer, G; Fassnacht, M; Fliedner, S; Januszewicz, A; Langton, K; Lenders, JWM; Masjkur, J; Megerle, F; Pamporaki, C; Pęczkowska, M; Peitzsch, M; Prejbisz, A; Rogowski-Lehmann, N; Sinnott, R; Timmers, HJLM; Tsourdi, E, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, L | 1 |
| Xie, W | 1 |
| Song, Z | 1 |
| Wang, T | 1 |
| Li, X | 1 |
| Gao, Y | 1 |
| Li, Y | 1 |
| Zhang, J | 1 |
| Guo, X | 1 |
| Eisenhofer, G | 2 |
| Prejbisz, A | 2 |
| Peitzsch, M | 2 |
| Pamporaki, C | 2 |
| Masjkur, J | 1 |
| Rogowski-Lehmann, N | 1 |
| Langton, K | 1 |
| Tsourdi, E | 1 |
| Pęczkowska, M | 2 |
| Fliedner, S | 1 |
| Deutschbein, T | 1 |
| Megerle, F | 1 |
| Timmers, HJLM | 1 |
| Sinnott, R | 2 |
| Beuschlein, F | 2 |
| Fassnacht, M | 1 |
| Januszewicz, A | 2 |
| Lenders, JWM | 1 |
| Därr, R | 1 |
| Miehle, K | 1 |
| Weismann, D | 1 |
| Bornstein, SR | 1 |
| Neumann, HP | 1 |
| Lenders, J | 1 |
| Jung, MC | 1 |
| Munro, N | 1 |
| Shi, G | 1 |
| Michael, AC | 1 |
| Weber, SG | 1 |
| Radjaipour, M | 1 |
| Raster, H | 1 |
| Liebich, HM | 1 |
| Willemsen, JJ | 2 |
| Ross, HA | 2 |
| Wolthers, BG | 2 |
| Sweep, CG | 2 |
| Kema, IP | 2 |
| Candito, M | 1 |
| Thyss, A | 1 |
| Albertini, M | 1 |
| Deville, A | 1 |
| Politano, S | 1 |
| Mariani, R | 1 |
| Chambon, P | 1 |
1 trial available for 3-methoxytyramine and Sensitivity and Specificity
| Article | Year |
|---|---|
Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Blood Specim | 2014 |
7 other studies available for 3-methoxytyramine and Sensitivity and Specificity
| Article | Year |
|---|---|
Addition of 3-methoxytyramine or chromogranin A to plasma free metanephrines as the initial test for pheochromocytoma and paraganglioma: Which is the best diagnostic strategy.
Topics: Adrenal Gland Neoplasms; Chromogranin A; Dopamine; Humans; Metanephrine; Paraganglioma; Pheochromocy | 2022 |
Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Chromaffin Cells; Dopamine; Fem | 2018 |
Use of tris(2,2'-bipyridine)osmium as a photoluminescence-following electron-transfer reagent for postcolumn detection in capillary high-performance liquid chromatography.
Topics: 2,2'-Dipyridyl; Chromatography, High Pressure Liquid; Coordination Complexes; Dopamine; Electrochemi | 2006 |
Quantification of urinary catecholamines, their abundant metabolites, and 5-hydroxyindoleacetic acid by high performance liquid chromatography and electrochemical detection, using a single mobile phase and uniform isocratic conditions.
Topics: Catecholamines; Chromatography, High Pressure Liquid; Dopamine; Electrochemistry; Homovanillic Acid; | 1994 |
Evaluation of specific high-performance liquid-chromatographic determinations of urinary adrenaline and noradrenaline by comparison with isotope dilution mass spectrometry.
Topics: Chromatography, High Pressure Liquid; Creatinine; Dopamine; Electrochemistry; Epinephrine; Female; G | 2001 |
Evaluation of specific high-performance liquid-chromatographic determinations of urinary metanephrine and normetanephrine by comparison with isotope dilution mass spectrometry.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Chromatography, High Pressure Liquid; Dopamine; Electrochemist | 2001 |
Methylated catecholamine metabolites for diagnosis of neuroblastoma.
Topics: Adolescent; Case-Control Studies; Child; Child, Preschool; Dopamine; Epinephrine; Female; Homovanill | 1992 |